Brazil, Ministry of Health, Secretária de Vigilância em Saúde, Programa Nacional de DST e Aids: Recomendações para Terapia Anti–retroviral em Adultos Infectados pelo HIV 2008 [http://www.ensp.fiocruz.br/portal-ensp/judicializacao/pdfs/491.pdf]
Dipiro J, Talbert R, Yees G, Matzke G, Wells B, Posey L: Pharmacotherapy: A Pathophysiologic Approach. 6th edition. Rio de Janeiro: Mcgraw Hill Companie; 2007.
Google Scholar
Okie S: Fighting HIV-Lessons from Brazil.
N Engl J Med 2006, 354:1977–1981.
Article
CAS
PubMed
Google Scholar
Ma A, Chen DM, Chau FM, Saberi P: Improving adherence and clinical outcomes through an HIV pharmacist’s interventions.
AIDS Care 2010, 22:1189–1194.
Article
PubMed
Google Scholar
Carcelero E, Tuset M, Martin M, De Lazzari E, Codina C, Miró J, Gatell J: Evaluation of antiretroviral-related errors and interventions by the clinical pharmacist in hospitalized HIV-infected patients.
HIV Med 2011, 12:494–499.
Article
CAS
PubMed
Google Scholar
Hirsch J, Gonzales M, Rosenquist A, Miller T, Gilmer T, Best B: Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
J Manag Care Pharm 2011, 17:213–223.
PubMed
Google Scholar
March K, Mak MM, Louie SG: Effects of pharmacists’ interventions on patient outcomes in an HIV primary care clinic.
Am J Heal Syst Pharm 2007, 64:2574–2578.
Article
Google Scholar
Mocroft A, Youle M, Moore A, Sabin CA, Madge S, Lepri AC, Tyrer M, Chaloner C, Wilson D, Loveday C, Johnson MA, Phillips AN: Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.
AIDS 2001, 15:185–194.
Article
CAS
PubMed
Google Scholar
Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM: The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review.
Patient Prefer Adherence 2012, 6:297–322.
Article
PubMed Central
PubMed
Google Scholar
Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL: Evidence of the economic benefit of clinical pharmacy services: 1996–2000.
Pharmacotherapy 2003, 23:113–132.
Article
PubMed
Google Scholar
Bozek PS, Perdue BE, Bar-Din M, Weidle PJ: Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection.
Am J Health Syst Pharm 1998, 55:1151–1155.
CAS
PubMed
Google Scholar
Engles-Horton LL, Skowronski C, Mostashari F, Altice FL: Clinical guidelines and pharmacist intervention program for HIV-infected patients requiring granulocyte colony-stimulating factor therapy.
Pharmacotherapy 1999, 19:356–362.
Article
CAS
PubMed
Google Scholar
Horberg M, Hurley L, Silverberg M, Kinsman C, Quesenberry C: Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy.
J Acquir Immune Defic Syndr 2007, 44:531–539.
Article
PubMed
Google Scholar
De Rijdt T, Willems L, Simoens S: Economic effects of clinical pharmacy interventions: a literature review.
Am J Health Syst Pharm 2008, 65:1161–1172.
Article
PubMed
Google Scholar
Areda CA, Bonizio RC, Freitas O: Pharmacoeconomy : an indispensable tool for the rationalization of health costs.
Braz J Pharm Sci 2011, 47:231–240.
Google Scholar
Bavinger C, Bendavid E, Niehaus K, Olshen RA, Olkin I, Sundaram V, Wein N, Holodniy M, Hou N, Owens DK, Desai M: Risk of cardiovascular disease from antiretroviral therapy for HIV : a systematic review.
PLoS One 2013, 8:e59551.
Article
PubMed Central
CAS
PubMed
Google Scholar
Dube MP: Disorders of glucose metabolism in patients infected with human immunodeficiency virus.
Clin Infect Dis 2000, 31:1467–1475.
Article
CAS
PubMed
Google Scholar
Friis-Møller N, Sabin CA, Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group, Weber R, D’Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD: Combination antiretroviral therapy and the risk of myocardial infarction.
N Engl J Med 2003, 349:1993–2003.
Article
PubMed
Google Scholar
Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, Ganesan A, Weintrob A, Barthel RV, Fraser S, Infectious Disease Clinical Research Program HIV Working Group, Agan BK: Increasing rates of obesity among HIV-infected persons during the HIV epidemic.
PLoS One 2010, 5:e10106.
Article
PubMed Central
PubMed
Google Scholar
Strand LM, Cipolle RJ, Morley PC: Documenting the clinical pharmacists activities: back to basics.
Drug Intell Clin Pharm 1988, 22:63–67.
CAS
PubMed
Google Scholar
University of Minnesota College of Pharmacy. Pharmacy workup notes [http://www.pharmacy.umn.edu/medmanagenotes/]
Molino CGRC, Carnevale RC, Rodrigues AT, Visacri MB, Moriel P, Mazzola PG: Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection.
Ther Clin Risk Manag 2014, 10:631–639.
PubMed Central
Google Scholar
DATASUS: SGTAP - Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e OPM do SUS [http://sigtap.datasus.gov.br/tabela-unificada/app/sec/inicio.jsp].
Ruiz I, Olry A, López MA, Prada JL, Causse M: Prospective, randomized, two-arm controlled study to evaluate two interventions to improve adherence to antiretroviral therapy in Spain.
Enferm Infecc Microbiol Clin 2010, 28:409–415.
Article
PubMed
Google Scholar
Martin S, Wolters P, Calabrese S, Toledo-Tamula MA, Wood LV, Roby G, Elliott-DeSorbo DK: The antiretroviral regimen complexity index. A novel method of quantifying regimen complexity.
J Acquir Immune Defic Syndr 2007, 45:535–544.
Article
PubMed
Google Scholar
Mok S, Minson Q: Drug-related problems in hospitalized patients with HIV infection.
Am J Health Syst Pharm 2008, 65:55–59.
Article
PubMed
Google Scholar
Rastegar D, Knight A, Monolakis J: Antiretroviral medication errors among hospitalized patients with HIV infection.
Clin Infect Dis 2006, 43:933–938.
Article
PubMed
Google Scholar
Pastakia S, Corbett A, Raasch R, Napravnik S, Correll T: Frequency of HIV-related medication errors and associated risk factors in hospitalized patients.
Ann Pharmacother 2008, 42:491–497.
Article
PubMed
Google Scholar
Misson J, Clark W, Kendall M: Therapeutic advances: protease inhibitors for the treatment of HIV-1 infection.
J Clin Pharm Ther 1997, 22:109–117.
Article
CAS
PubMed
Google Scholar
Osterberg L, Blaschke T: Adherence to medication.
N Engl J Med 2005, 353:487–497.
Article
CAS
PubMed
Google Scholar
Langford SE, Ananworanich J, Cooper DA: Predictors of disease progression in HIV infection : a review.
Aids Res Ther 2007, 4:1–14.
Article
Google Scholar
Brazil, Ministry of Health, Secretaria de Vigilancia em Saúde, Departamento de DST Aids e Hepatites Virais: Boletim Epidemiológico - AIDS e DST. 2012 [http://www.aids.gov.br/sites/default/files/anexos/publicacao/2011/50652/boletim_aids_2011_final_m_pdf_26659.pdf]
McPherson-Baker S, Malow RM, Penedo F, Jones DL, Schneiderman N, Klimas NG: Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men.
AIDS Care 2000, 12:399–404.
Article
CAS
PubMed
Google Scholar
Shen J, Sun Q, Zhou X, Wei Y, Qi Y, Zhu J, Yan T: Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital.
Int J Clin Pharm 2011, 33(6):929–933.
Article
PubMed
Google Scholar
Yen Y-H, Chen H-Y, Wuan-Jin L, Lin Y-M, Shen WC, Cheng K-J: Clinical and economic impact of a pharmacist-managed i.v.-to-p.o. conversion service for levofloxacin in Taiwan.
Int J Clin Pharmacol Ther 2012, 50:136–141.
Article
CAS
PubMed
Google Scholar
Brennan TA, Dollear TJ, Hu M, Matlin OS, Shrank WH, Choudhry NK, Grambley W: An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients.
Health Aff (Millwood) 2012, 31:120–129.
Article
Google Scholar
Lee AJ, Boro MS, Knapp KK, Meier JL, Korman NE: Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center.
Am J Health Syst Pharm 2002, 59:2070–2077.
PubMed
Google Scholar
Janknegt R, Meer JWM van der: Sequential therapy with intravenous and oral cephalosporins.
J Antimicrob Chemother 1994, 33:169–177.
Article
CAS
PubMed
Google Scholar
Brazilian Health Surveillance Agency (ANVISA): Preços máximos de medicamentos por princípio ativo para compras públicas – monodrogas/ preços fábrica (PF) e preço máximo de venda ao governo (PMVG) [
http://portal.anvisa.gov.br/wps/wcm/connect/de29e2004baf729293c5dbbc0f9d5b29/LISTA_CONFORMIDADE_GOV_2012-06-19.pdf?MOD=AJPERES. Accessed July 12, 2014].